Skip to content
10-K/A

Annual Report

CYCLO THERAPEUTICS, INC.

0001437749-24-037835

← back to feed
Filed
Dec 18, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 15, 2024 28.72M sh
Capex FY 2024 · Dec 31, 2023 $2.42K
Capex FY 2024 · Dec 31, 2022 $15.09K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$16.19M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$15.11M
Cash And Equivalents FY 2024 · Dec 31, 2023 $9.25M
Cash And Equivalents FY 2024 · Dec 31, 2022 $1.54M
Stockholders Equity FY 2024 · Dec 31, 2023 $4.76M
Stockholders Equity FY 2024 · Dec 31, 2022 $734.54K
Stockholders Equity FY 2024 · Dec 31, 2021 $15.67M
Current Liabilities FY 2024 · Dec 31, 2023 $8.47M
Current Liabilities FY 2024 · Dec 31, 2022 $3.48M
Current Assets FY 2024 · Dec 31, 2023 $12.32M
Current Assets FY 2024 · Dec 31, 2022 $4.16M
Total Assets FY 2024 · Dec 31, 2023 $13.25M
Total Assets FY 2024 · Dec 31, 2022 $4.22M
Eps Basic FY 2024 · Dec 31, 2023 −$1.23
Eps Basic FY 2024 · Dec 31, 2022 −$1.83
Rd Expense FY 2024 · Dec 31, 2023 $14.18M
Rd Expense FY 2024 · Dec 31, 2022 $9M
Net Income FY 2024 · Dec 31, 2023 −$20.06M
Net Income FY 2024 · Dec 31, 2022 −$15.45M
Operating Income FY 2024 · Dec 31, 2023 −$20.05M
Operating Income FY 2024 · Dec 31, 2022 −$15.62M
Gross Profit FY 2024 · Dec 31, 2023 $992.04K
Gross Profit FY 2024 · Dec 31, 2022 $1.24M